Ascendis Pharma A/S et al. vs. BioMarin Pharmaceutical Inc.
Explore the PTAB proceeding PGR2026-00013 filed by Ascendis Pharma A/S et al. on 2025-11-24. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
PGR2026-00013
Filing Date
2025-11-24
Accorded Filing Date
2025-11-24
Institution Decision Date
2026-05-06
Last Modified Date
2026-09-30
Proceeding Type
PGR
Termination Date
2026-09-30
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Ascendis Pharma A/S et al.
Represented By
Holman, Davidet alPatent Owner / Respondent
BioMarin Pharmaceutical Inc.
Represented By
Modi, Naveenet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34824 | Robert Gerstein | +1 312-474-6300 |
| 35302 | Greta Noland | +1 312-474-6300 |
| 38153 | David Gass | +1 312-474-6300 |
| 45790 | Heather Kissling | +1 312-474-6300 |
| 45974 | Luisa Bigornia | +1 415-506-6700 |
| 48484 | Sharon Sintich | +1 312-474-6300 |
| 52664 | Eric Brusca | +1 312-474-6300 |
| 53066 | Lynn Janulis | +1 312-474-6300 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 12,233,106 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2025017021 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2021632202 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2022633501 | US Continuation / Sibling | View Official Patent → |
ZYDUS LIFESCIENCES LIMITED et al. v. BioMarin Pharmaceutical Inc.